The FDA granted zongertinib Breakthrough Therapy Designation for patients with HER2 (ERBB2)-mutant advanced NSCLC as an initial treatment. The FDA also awarded a Commissioner's National Priority ...

This press release is not intended for UK mediaHERNEXEOS® (zongertinib tablets) approved based on an objective response rate of 76% (N=72) as ...

The gutting of HIV drug programs isn't just bad policy; it threatens a repeat of history's deadliest mistake, writes John ...

A new study provides hope that smarter timing of cancer treatments could improve cure rates. The study's Principal Investigator, Dr. Robert Noble, Senior Lecturer at the Department of Mathematics, ...

Day One Biopharmaceuticals stock remains a "Strong Buy." Learn more about its outlook, surging revenue, and ADC pipeline ...

A program in Idaho that paid parents and spouses to be full-time caregivers for their family members with disabilities was ...

Eric Dane died after battling ALS. Here’s what to know about ALS, the progressive neurological disease that affects nerve cells and has no known cure.

Koalas’ population comeback may be doing more than boosting numbers—it could also be rebuilding their lost genetic diversity.

CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...

The Idaho Department of Health and Welfare ended the program in July. Families who provide their own in-home care hope for ...

Victor Davis Hanson, a senior contributor for The Daily Signal, is a classicist and historian at the Hoover Institution at ...

A new study provides hope that smarter timing of cancer treatments could improve cure rates. The study's Principal Investigator, Dr Robert Noble, Senior Lecturer at the Department of Mathematics, City ...